3A: Significant correlations with anemia | |||||||
---|---|---|---|---|---|---|---|
All patients N = 290 (%) | Patients with anemia gr 3–4 N = 57 (19.6%) | Patients without anemia gr 3–4 N = 233 (80.3%) | Unadjusted OR (95%CI) | *p-value | Adjusted OR (95% CI) | **Corrected p value | |
ABCB1 rs1128503 | CC 94 (32.4) | 13 (22.8) | 81 (34.8) | 1.58 (1.03; 2.42) | 0.035 | 1.71 (1.07; 2.71) | 0.023 |
CT 147 (50.7) | 30 (52.6) | 117 (50.2) | |||||
TT 49 (16.9) | 14 (24.6) | 35 (15.0) | |||||
ABCC2 rs12762549 | CC 80 (27.6) | 25 (43.8) | 55 (23.6) | 0.55 (0.36; 0.83) | 0.005 | 0.51 (0.33; 0.81) | 0.004 |
CG132 (45.5) | 22 (38.6) | 110 (47.2) | |||||
GG 76 (26.2) | 10 (17.5) | 66 (28.3) | |||||
ABCA1 rs363717 | AA 86 (29.6) | 10 (17.5) | 76 (32.6) | 1.31 (1.98; 2.99) | 0.001 | 2.08 (1.32; 3.27) | 0.002 |
GA 131 (45.2) | 23 (40.3) | 108 (33.5) | |||||
GG 73 (25.2) | 24 (42.1) | 49 (15.2) | |||||
ERCC1 rs11615 | TT 133 (45.9) | 18 (31.6) | 115 (49.3) | 1.58 (1.06-2.35) | 0.024 | 1.61 (1.04-2.50) | 0.031 |
TC 114 (39.3) | 28 (49.1) | 86 (36.9) | |||||
CC 42 (14.5) | 11 (19.3) | 31 (13.3) | |||||
3B: Significant correlations with thrombocytopenia (TCP) | |||||||
All patients | Patients with TCP gr 3 – 4 | Patients without TCP gr 3 – 4 | Unadjusted OR | *p-value | Adjusted OR | **Corrected p value | |
N = 290 (%) | N = 57 (19.6%) | N = 233 (80.3%) | (95%CI) | (95% CI) | |||
CYP3A4 rs4986910 | TT 280 (96.5) | 51(89.5) | 229(98.3) | 5.61 (1.46; 21.64) | 0.012 | 4.99 (1.22; 20.31) | 0.025 |
CT 9 (3.1) | 5(8.8) | 4(1.7) | |||||
CC 0 (0) | 0 | 0 |